Preview

Pediatric pharmacology

Advanced search

ROLE OF MAGNESIUM IN HEADACHE PATHOGENESIS IN CHILDREN AND ADOLESCENTS

https://doi.org/10.15690/pf.v10i2.645

Abstract

Article is dedicated to the problem of headache in children. This pathology is being found more frequently in pediatric and children’s neurologic practice. The authors examine headache pathogenesis from the position of magnesium deficiency. Analysis of results of the modern studies on magnesium deficiency and its correction in patients with headache indicates that magnesium metabolism may play an important role both in pathogenesis of different headache types and in its treatment and prevention.


About the Authors

E. S. Akarachkova
First Sechenov Moscow State Medical University, Russian Federation
Russian Federation


S. V. Vershinina
First Sechenov Moscow State Medical University, Russian Federation
Russian Federation


O. V. Kotova
First Sechenov Moscow State Medical University, Russian Federation
Russian Federation


I. V. Ryabokon'
First Sechenov Moscow State Medical University, Russian Federation
Russian Federation


References

1. Headache classification subcommittee of the international headache society: the international classifi cation of headache disorders, 2nd edn. Cephalalgia. 2004; 24 (Suppl) :1–150.

2. Акарачкова Е.С. К вопросу диагностики и лечения психовегетативных расстройств в общесоматической практике. Лечащий врач. 2010; №10: 60–64.

3. Громова О.А. Магний и пиридоксин: основы знаний. М., 2006: 223.

4. Dhillon K.S., Singh J., Lyall J.S. A new horizon into the pathobiology, etiology and treatment of migraine. Med. Hypotheses. 2011 Jul; 77 (1): 147–51.

5. Акарачкова Е.С. Роль вегетативной нервной системы в патогенезе головной боли напряжения. Автореф. дисс… д.м.н. — М, 2012: 48.

6. Altura B.M., Altura B.T. Tension headaches and muscle tension: is there a role for magnesium? Med. Hypotheses. 2001 Dec; 57(6): 705–13.

7. Chen Y. Advances in the pathophysiology of tension-type headache: from stress to central sensitization. Curr. Pain Headache Rep. 2009 Dec; 13 (6): 484–94.

8. Mauskop A., Altura B.T., Altura B.M. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002 Apr; 42 (4): 242–8.

9. Available at: http://www.stanford.edu/group/hopes/cgi-bin/wordpress/2011/06/about-glutamate-toxicity/).

10. Mauskop A., Varughese J. Why all migraine patients should be treated with magnesium. J. Neural. Transm. 2012 May; 119 (5): 575–9.

11. Pringsheim T., Davenport W., Mackie G., Worthington I., Aubé M., Christie S.N., Gladstone J., Becker W.J. Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can. J. Neurol. Sci. 2012 Mar; 39 (2 Suppl. 2): Р. 1–59.

12. Memon Z.I., Altura B.T., Benjamin J.L., Cracco R.Q., Altura B.M. Predictive value of serum ionized but not total magnesium levels in head injuries. Scand. J. Clin. Lab. Invest. 1995 Dec; 55 (8): 671–7.

13. Sartori S.B., Whittle N., Hetzenauer A., Singewald N. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology. 2012 Jan; 62 (1): 304–12.

14. Акарачкова Е.С., Вершинина С.В. Синдром вегетативной дистонии у детей и подростков. Педиатрия. Журнал им. Г.Н. Сперанского. 2011; 6: 30–34

15. Silberstein S.D., Goadsby P.J. Migraine: preventive treatment. Cephalalgia. 2002; 22: 491–512.

16. Snow V., Weiss K., Wall E.M., Mottur-Pilson C., American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann. Intern. Med. 2002; 137: 840–9.

17. Torshin I.Yu., Gromova O.A. Magnesium and pyridoxine: the basics. Nova Science, 2009: 221 p.

18. Громова О.А. и др. Мировой опыт применения цитрата магния в медицине. Трудный пациент. 2010; Т. 8 (№8): 35–38.

19. Walker A.F., Marakis G., Christie S., Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003; 16 (3): 183–191.

20. Evers S. Alternatives to beta blockers in preventive migraine treatment. Nervenarzt. 2008; 79 (10): 1135–6, 1138–1340, 1142–3.

21. Grazzi L., Andrasik F., Usai S., Bussone G. Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci. 2007 Jun; 28 (3): 148–50.

22. Артеменко А.Р., Куренков А.Л. Хроническая мигрень. М.: АБВ-пресс, 2012: 400.

23. Modi S., Lowder D.M. Medications for migraine prophylaxis. Am. Fam. Physician. 2006 Jan 1; 73 (1): 72–8.

24. Магне Б6: Инструкция по медицинскому применению.

25. Магне Б6 Форте: Инструкция по медицинскому применению.


Review

For citations:


Akarachkova E.S., Vershinina S.V., Kotova O.V., Ryabokon' I.V. ROLE OF MAGNESIUM IN HEADACHE PATHOGENESIS IN CHILDREN AND ADOLESCENTS. Pediatric pharmacology. 2013;10(2):57-62. https://doi.org/10.15690/pf.v10i2.645

Views: 1620


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)